FDA Inspection 1274326 — Orient Pharma Co., Ltd.
The FDA completed an inspection of Orient Pharma Co., Ltd. on May 23, 2025 in Yunlin County. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 23, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yunlin County (Taiwan)